These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 30568655)

  • 1. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature.
    Shan F; Long Y; Qiu W
    Front Immunol; 2018; 9():2802. PubMed ID: 30568655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients.
    Li T; Li X; Hong S; Jiang L; Ma J
    J Neuroimmunol; 2023 Sep; 382():578176. PubMed ID: 37572437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune glial fibrillary acidic protein astrocytopathy resembling isolated central nervous system lymphomatoid granulomatosis.
    Kimura A; Kato S; Takekoshi A; Yoshikura N; Yanagida N; Kitaguchi H; Akiyama D; Shimizu H; Kakita A; Shimohata T
    J Neuroimmunol; 2021 Dec; 361():577748. PubMed ID: 34653948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus: To be a trigger of autoimmune glial fibrillary acidic protein astrocytopathy?
    Li XL; Wang JY; Li LK; Yang CL; Zhao XL; Yang B; Zhang P; Liu B; Li YB; Zhang ZX; Duan RS
    CNS Neurosci Ther; 2023 Dec; 29(12):4139-4146. PubMed ID: 37458208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune GFAP astrocytopathy after viral encephalitis: A case report.
    Li J; Xu Y; Ren H; Zhu Y; Peng B; Cui L
    Mult Scler Relat Disord; 2018 Apr; 21():84-87. PubMed ID: 29499442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis.
    Fang B; McKeon A; Hinson SR; Kryzer TJ; Pittock SJ; Aksamit AJ; Lennon VA
    JAMA Neurol; 2016 Nov; 73(11):1297-1307. PubMed ID: 27618707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune glial fibrillary acidic protein astrocytopathy with anti-NMDAR and sulfatide-IgG-positive encephalitis overlap syndrome: A case report and literature review.
    Cui RM; Fan FR; Ma SH; Li H; Li JC; Wen Y; Liu MW
    Medicine (Baltimore); 2024 Jul; 103(28):e38983. PubMed ID: 38996095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalitis with radial perivascular emphasis: Not necessarily associated with GFAP antibodies.
    Wickel J; Chung HY; Kirchhof K; Boeckler D; Merkelbach S; Kuzman P; Mueller WC; Geis C; Günther A
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32019875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune glial fibrillary acidic protein astrocytopathy manifesting as subacute meningoencephalitis with descending myelitis: a case report.
    Wang H; Chin JH; Fang BY; Chen X; Zhao AL; Ren HT; Guan HZ
    BMC Neurol; 2020 Dec; 20(1):443. PubMed ID: 33297961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune glial fibrillary acidic protein astrocytopathy in children: a retrospective study.
    Zhuang X; Jin K; Li X; Li J
    Eur J Med Res; 2022 Jan; 27(1):11. PubMed ID: 35065659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting with Area Postrema Syndrome-Like Symptoms without Medulla Oblongata Lesions.
    Iwami K; Nomura T; Seo S; Nojima S; Tsuzaka K; Kimura A; Shimohata T; Yabe I
    Neuroimmunomodulation; 2022; 29(4):433-438. PubMed ID: 35421859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases.
    Fang H; Hu W; Jiang Z; Yang H; Liao H; Yang L; Wu L
    Front Immunol; 2021; 12():761354. PubMed ID: 34880859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purkinje cell (PC) antibody positivity in a patient with autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy.
    Xu L; Xian W; Li J; Yao X; Long Y
    Int J Neurosci; 2022 Oct; 132(10):1043-1048. PubMed ID: 33287611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.
    Flanagan EP; Hinson SR; Lennon VA; Fang B; Aksamit AJ; Morris PP; Basal E; Honorat JA; Alfugham NB; Linnoila JJ; Weinshenker BG; Pittock SJ; McKeon A
    Ann Neurol; 2017 Feb; 81(2):298-309. PubMed ID: 28120349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack.
    Yang X; Huang Q; Yang H; Liu S; Chen B; Liu T; Yang J; Yao H; Lin S; Chen X; Zhuang H; Long Y; Gao C
    Mult Scler Relat Disord; 2019 Apr; 29():94-99. PubMed ID: 30690341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune encephalitis in glial fibrillary acidic protein astrocytopathy.
    Zhao CW; Gheihman G; Nigam M; Manzano GS
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38724215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study.
    Long Y; Liang J; Xu H; Huang Q; Yang J; Gao C; Qiu W; Lin S; Chen X
    Eur J Neurol; 2018 Mar; 25(3):477-483. PubMed ID: 29193473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typical linear radial periventricular enhancement in a patient with glial fibrillary acidic protein (GFAP) astrocytopathy.
    Lin J; Lu L; Li J
    Neurol Sci; 2022 Apr; 43(4):2895-2897. PubMed ID: 35146565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.
    Iorio R; Damato V; Evoli A; Gessi M; Gaudino S; Di Lazzaro V; Spagni G; Sluijs JA; Hol EM
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):138-146. PubMed ID: 28951498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: Atypical case of autoimmune glial fibrillary acidic protein astrocytopathy following COVID-19 vaccination refractory to immunosuppressive treatments.
    Morishima Y; Hata T; Nakajima S; Shindo K; Tsuchiya M; Watanabe T; Tahara I; Kondo T; Kimura A; Shimohata T; Ueno Y
    Front Immunol; 2024; 15():1361685. PubMed ID: 38665914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.